» Authors » Ioannis Tomos

Ioannis Tomos

Explore the profile of Ioannis Tomos including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 34
Citations 118
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Fabbri L, Althobiani M, Tomos I, Planas-Cerezales L, Wijsenbeek M, Kreuter M, et al.
ERJ Open Res . 2025 Mar; 11(2). PMID: 40071274
https://bit.ly/3WAhw19.
2.
Tomos I, Grigoropoulos I, Kosti C, Chrysikos S, Digalaki A, Thomas K, et al.
Expert Rev Respir Med . 2025 Feb; :1-9. PMID: 40017107
Background: Immunomodulators tocilizumab and baricitinib have been used for the treatment of severe COVID-19, however, there are only few published studies comparing their efficacy. Research Design And Methods: All consecutive...
3.
Tomos I, Antonogiannaki E, Dimakopoulou K, Raptakis T, Apollonatou V, Kallieri M, et al.
Expert Rev Respir Med . 2025 Feb; :1-8. PMID: 40007128
Background: The use of lung ultrasound (LUS) has recently become vital in the diagnosis and prognosis of various respiratory diseases. Its role in COVID-19 requires further investigation. Research Design And...
4.
Tomos I, Kanellopoulou P, Nastos D, Aidinis V
Expert Opin Ther Targets . 2025 Feb; 29(1-2):43-57. PMID: 39985559
Introduction: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive interstitial lung disease with a dismal prognosis. While the standard-of-care (SOC) drugs approved for IPF represent a significant advancement in antifibrotic...
5.
Matthaiou A, Tomos I, Bizymi N, Vamvakaris I, Anagnostopoulos N, Papadopoulou A, et al.
Biomol Biomed . 2025 Jan; PMID: 39888726
SWItch/sucrose non-fermentable (SWI/SNF) is a large protein complex with a central role in chromatin remodeling and genome transcription. The catalytic subunits of the SWI/SNF related BAF chromatin remodeling complex subunit...
6.
Antonogiannaki E, Grigoropoulos I, Manali E, Thomas K, Kallieri M, Alexopoulou P, et al.
J Clin Med . 2025 Jan; 14(2. PMID: 39860353
: Long-term lung sequelae in severe COVID-19 survivors, as well as their treatment, are poorly described in the current literature. : To investigate lung fibrotic sequelae in survivors of severe/critical...
7.
Guiot J, Henket M, Gester F, Andre B, Ernst B, Frix A, et al.
Respir Res . 2025 Jan; 26(1):39. PMID: 39856708
Background: Systemic sclerosis (SSc) is a rare connective tissue disease associated with rapidly evolving interstitial lung disease (ILD), driving its mortality. Specific imaging-based biomarkers associated with the evolution of lung...
8.
Kotsiou O, Kirgou P, Tzouvelekis A, Kolilekas L, Manali E, Papiris S, et al.
Sarcoidosis Vasc Diffuse Lung Dis . 2024 Dec; 41(4):e2024055. PMID: 39655591
Background And Aim: There is limited data on the prevalence of SARS-COV-2 in sarcoidosis patients and the underlying parameters linked to severity. We aimed to conduct a national multicenter study...
9.
Tomos I, Papaioannou A, Daniil Z, Dimeas I, Kirgou P, Gogali A, et al.
Adv Respir Med . 2024 Nov; 92(6):466-471. PMID: 39584853
: Depression and anxiety represent significant comorbidities in idiopathic pulmonary fibrosis (IPF) patients, affecting their quality of life. The COVID-19 pandemic has had an uneven impact on global mental health....
10.
Dimakopoulou K, Tomos I, Manali E, Papiris S, Karakatsani A
Expert Rev Respir Med . 2023 Nov; 17(11):1069-1078. PMID: 37937867
Background: Lately a potential detrimental effect of air pollution to idiopathic pulmonary fibrosis emerged. We aimed to assess the effects of short-term air pollution exposure to the clinical course of...